Mark Mallon is executive vice president, international, at AstraZeneca. He is responsible for the growth and performance of AstraZeneca’s commercial businesses in various regions, including Asia Pacific, Russia, Latin America, the Middle East and Africa. Since joining AstraZeneca in 1994, he has held multiple senior sales and marketing roles, including regional vice president for Asia Pacific, president of AstraZeneca’s Chinese and Italian subsidiaries, chief operating officer of AstraZeneca’s Japanese subsidiary and vice president of AstraZeneca’s U.S. gastrointestinal and respiratory businesses. He has served as a member of the board of directors for Christiana Care, the largest hospital system in Delaware, and an executive committee member for the R&D-based Pharmaceutical Association Committee, the China industry association for innovative pharmaceutical companies. He holds a degree in chemical engineering from the University of Pennsylvania and a master’s in business administration in marketing and finance from the Wharton School of Business, Pennsylvania.
